CClinicalTrials.gg
RecruitingNCT06270550Updated Feb 12, 2025

Role of Dynamic Movement Intervention in Children with Spastic Diplegia

An interventional study of Dynamic Movement Intervention in Spastic Diplegia, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 4 Years to 7 Years. Per ClinicalTrials.gov, last updated 2025-02-12.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
4 Years to 7 Years
Sex
All
01

Study summary

The study aims to investigate the effect of dynamic movement intervention approach on static and dynamic balance, quality of step length and cadence of walking pattern of children with spastic diplegic cerebral palsy.

02

Conditions studied

  • Spastic Diplegia

Keywords

  • Dynamic Movement Intervention
03

In context

Muscle Spasticity

703 studies on the registry are indexed under Muscle Spasticity; 148 are open to participants now.

This study's planned enrollment of 40 is above the median of 36 across 524 interventional studies indexed under Muscle Spasticity.

Browse Muscle Spasticity studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ranged from 4-7 years.
  • They can walk alone short distance and climb stairs holding on rail (Grade I \& II according to GMFCS).
  • They can understand and execute instructions.
  • They will be medically stable.
  • Degree of spasticity will be ranged from 1 to 1+ degree according to the Modified Ashworth Scale.

Exclusion criteria

Exclusion criteria:

  • Visual impairment (visual loss- cataract- myopia- hyperopia).
  • Hearing impairment (deafness)
  • Cognitive problem.
  • Uncontrolled Convulsions.
  • Orthopedic surgery for the affected lower limbs within one year.
  • Botulinum toxin injection within the last 6 months or within the study period.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Dynamic movement intervention based group.

    Other: Dynamic Movement Intervention

  • Experimental
    Selective physical therapy program based group.

    Other: Dynamic Movement Intervention

Interventions

  • OtherDynamic Movement Intervention

    Dynamic movement intervention is a physical therapy approach for infants suffering abnormal developmental motor evolution caused by a known or unknown non-degenerative syndrome affecting the central nervous system

06

What researchers measure

Primary outcomes

  1. Effect of Dynamic movement intervention on balance and quality of walking of the study group compared to control group, measured using Humac Balance System.

    Effect of Dynamic movement intervention on balance and quality of walking of the study group compared to control group with different intervention. As balance will be assessed using Humac Balance System.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • Cairo University
    Cairo, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06270550
Lead sponsor
Cairo University
Responsible party
Mahmoud Abdel Aziz Abdel Aziz Awara (Bachelor's degree in Physical Therapy, Cairo University) — Principal investigator
First posted
Feb 21, 2024
Start date
Mar 1, 2025 (estimated)
Primary completion
Aug 1, 2025 (estimated)
Completion
Sep 1, 2025 (estimated)
Last update
Feb 12, 2025

Study contacts

Mahmoud Awara, B.Sc
Contact
crawara07@gmail.com
+201013829575

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion